Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemiaJane Houldsworth, R. S. K. Chaganti, Geetu Mendiratta et al.|Leukemia & lymphoma/Leukemia and lymphoma|2013Cited by 33
Systematic Analysis of Cell-of-Origin, Sequencing and Genomic Imbalances Identifies a Distinct Subset of Rituximab Treated Diffuse Large B-Cell Lymphoma with an Inferior SurvivalRajan Dewar, Robin Joyce, Julia Friedman et al.|Blood|2015Cited by 0